Clinical Trials Arena on MSN
Cystic Fibrosis Foundation backs Israeli biotech with $13m to develop inhaled drug
SpliSense is currently conducting a Phase IIb trial with its antisense oligonucleotide therapy.
Editor's note: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...
Leah J. Witt, MD: Hello. I'm Dr Leah Witt. Welcome to season one of Medscape InDiscussion, chronic obstructive pulmonary disease (COPD) podcast series. Today we're talking medications, especially ...
Please provide your email address to receive an email when new articles are posted on . Invited patients had 32% of days covered for maintenance inhalers, whereas control patients had a smaller ...
Asthma Drug Albuterol Shortage Is About To Worsen: Here’s Why—And How Hospitals Are Filling The Gaps
Several major manufacturing plants for the asthma and respiratory drug Albuterol have shut down, possibly worsening an already-flaring shortage of the medication that has forced hospitals to devise ...
Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, affects more than 30 million Americans and is the fourth leading cause of death worldwide. Many people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results